BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 3549265)

  • 1. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
    Adamafio NA; Cameron CM; Kostyo JL
    Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
    Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
    Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
    Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
    Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone inhibits activation of phosphatidylinositol phospholipase C by insulin in ob/ob mouse adipose tissue.
    Chou SY; Kostyo JL; Adamafio NA
    Endocrinology; 1990 Jan; 126(1):62-6. PubMed ID: 2403523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
    Cameron CM; Kostyo JL; Rillema JA; Gennick SE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age on responsiveness to diabetogenic action of growth hormone.
    Cameron CM; Kostyo JL
    Diabetes; 1987 Jan; 36(1):88-92. PubMed ID: 3539676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouse.
    Kostyo JL; Gennick SE; Sauder SE
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E356-60. PubMed ID: 6720889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
    Gennick SE; Kostyo JL; Mills JB; Eden S
    Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated adipocytes from growth hormone-treated obese (ob/ob) mice exhibit insulin resistance.
    Roupas P; Towns RJ; Kostyo JL
    Biochim Biophys Acta; 1990 May; 1052(2):341-4. PubMed ID: 2110483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function.
    Roupas P; Chou SY; Towns RJ; Kostyo JL
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1691-5. PubMed ID: 1848008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some biochemical effects of the growth hormone analogue produced by plerocercoids of the tapeworm Spirometra mansonoides on carbohydrate metabolism of adipose tissue from normal, diabetic, and hypophysectomized rats.
    Salem MA; Phares CK
    J Parasitol; 1986 Aug; 72(4):498-506. PubMed ID: 3537254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different growth hormone-receptor interactions mediate insulin-like and lipolytic responses of rat adipose tissue.
    Chipkin SR; Szecowka J; Tai LR; Kostyo JL; Goodman HM
    Endocrinology; 1989 Jul; 125(1):450-8. PubMed ID: 2500331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmammalian growth hormones have diabetogenic and insulin-like activities.
    Cameron CM; Kostyo JL; Papkoff H
    Endocrinology; 1985 Apr; 116(4):1501-5. PubMed ID: 3882411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
    Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.